Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing
- 4 July 2022
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 137 (1-2) , 1-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemiaProceedings of the National Academy of Sciences, 2013
- 2A peptides provide distinct solutions to driving stop-carry on translational recodingNucleic Acids Research, 2011
- Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene deliveryGene Therapy, 2011
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and MicePLOS ONE, 2011
- Liver-Directed Recombinant Adeno-Associated Viral Gene Delivery Rescues a Lethal Mouse Model of Methylmalonic Acidemia and Provides Long-Term Phenotypic CorrectionHuman Gene Therapy, 2010
- Long-term Rescue of a Lethal Murine Model of Methylmalonic Acidemia Using Adeno associated Viral Gene TherapyMolecular Therapy, 2010
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenBlood, 2009
- Mitochondrial dysfunction in mut methylmalonic acidemiaThe FASEB Journal, 2008
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscleBMC Medical Genetics, 2007